A clinical study of MK-4716 in people with certain solid tumors (MK-4716-001)

Trial Identifier: 4716-001
Sponsor: MSD
Start Date: December 2025
Primary Completion Date: December 2030
Study Completion Date: December 2030
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary - English

Trial Locations

Country Location
Australia, New South Wales Sydney, New South Wales, Australia, 2148
Australia, Western Australia Nedlands, Western Australia, Australia, 6009
Chile, Region M. de Santiago Santiago, Region M. de Santiago, Chile, 8420383
Chile, Region M. de Santiago Santiago, Region M. de Santiago, Chile, 8330073
Israel, N/A Haifa, N/A, Israel, 3109601
Israel, N/A Petah-Tikva, N/A, Israel, 4941492
Israel, N/A Ramat Gan, N/A, Israel, 5265601
Korea, Republic of, Seoul Seoul, Korea, Republic of, 05505
Korea, Republic of, Seoul Seoul, Korea, Republic of, 03080
Spain, Barcelona Barcelona, Spain, 08036
Spain, Barcelona Barcelona, Spain, 08035
Spain, Madrid Madrid, Spain, 28040
United States, NJ New Brunswick, NJ, United States, 08903
United States, TX Irving, TX, United States, 75039
United States, VA Fairfax, VA, United States, 22031